AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 182 min read$ARE

Alexandria Real Estate Equities Stock: Is ARE Underperforming the Real Estate Sector?

Alexandria Real Estate Equities (ARE), a mid-cap life science REIT, reported Q2 2026 adjusted FFO of $1.73 per share, beating estimates, but revenue fell 13% YoY to $662.78M. ARE stock is up 14.3% YTD but down 34.3% over 52 weeks, underperforming the XLRE ETF. Analysts have a 'Hold' consensus rating with a mean price target of $53.

Original reporting
yahoo.com
Published Sep 18, 2026, 11:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 11:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Alexandria Real Estate Equities Stock: Is ARE Underperforming the Real Estate Sector? — source image
Source · yahoo.com
Decision brief

The 30-second read

$AREBearishMed
01

Why it matters

Earnings miss and narrowed guidance suggest near‑term earnings pressure, likely weighing on the stock and sector.

02

Market read

ARE's earnings shortfall may trigger sector‑wide reassessment of life‑science REIT valuations.

03

What to watch

Potential upside from upcoming capital transactions and delayed dispositions could improve cash flow later in the year.

Relevance 8/10Novelty 8/10Timing: post‑earnings day, shares tumbled next day

Background

ARE is a mid‑cap life‑science REIT with a $9.3 B market cap; Q2 results showed revenue and rental income declines.

Company-level read

Ticker impact

$AREBearishMedium confidence
Context

Q2 2026 adjusted FFO of $1.73 per share reported; revenue down 13% YoY; guidance narrowed to $6.35‑$6.45 per share; stock fell 7.8% after release.

Expected impact

Potential further decline of 3‑5% over the next week if guidance holds.

Evidence & confidence

Revenue and rental income fell sharply; guidance below consensus; market reaction already negative.

Market effects

Sector

Life‑science REIT sector may see pressure as peers' earnings underperform.

Regional

U.S. REIT market could see modest pullback amid weaker real‑estate income data.

Global

Limited to U.S. REIT investors; no broader macro effect.

Counterpoint

What could challenge this read

If the market overreacts, the dip could present a buying opportunity at a discount.

Key entities

  • Company
    Alexandria Real Estate Equities, Inc.

    Life‑science REIT reporting Q2 2026 results.

Read at source← All news

Related articles

OCT 12
$AREHigh

BMO downgrades Alexandria Real Estate stock rating on earnings outlook

BMO Capital downgraded Alexandria Real Estate Equities (NYSE:ARE) to Underperform, lowering its price target to $41 from $48. The stock is down 35% over the past year. BMO forecasts a 26.3% decline in 2027 Core FFO per share, citing rising interest rates and life science vacancy as headwinds. ARE reported mixed Q2 2026 results, with revenue exceeding expectations but adjusted earnings per share missing estimates.

investing.com1 min
OCT 7
$AREMed

Alexandria Real Estate Equities (ARE) Could Be 13% Below Fair Value On New $5 Billion Credit Deal

Alexandria Real Estate Equities (ARE) executed a $5 billion unsecured revolving credit facility with maturities extended to 2032. The company's shares trade at $45.92, down 12.78% over 30 days and 37.66% over one year. Analysts suggest a fair value of $52.57, indicating a potential 13% undervaluation, but note challenges from an 86.9% occupied portfolio and recent property impairments.

simplywall.st2 min
OCT 3
$AREMedAI 8/10

Should Extended Credit Line Require Action From Alexandria Real Estate Equities (ARE) Investors?

Alexandria Real Estate Equities (ARE) secured a US$5 billion unsecured revolving credit line, extendable to US$6 billion, maturing by January 2032. The agreement modifies debt treatment and removes sustainability margin adjustments, impacting balance sheet management. Analysts forecast 2029 revenues of US$2.5 billion and earnings of US$278.8 million, with varying outlooks on asset recycling and leasing demand.

simplywall.st2 min
SEP 16
$AREMed

Alexandria Real Estate Equities spared from class action suit

A judge dismissed a class action lawsuit against Alexandria Real Estate Equities, alleging false statements about a Queens property. The case was dismissed without prejudice. Alexandria's stock is down 38% over the past year, trading at $52.82. The company faces potential $183M preconstruction cost issues for a Manhattan project.

therealdeal.com2 min
SEP 6
$AREHighAI 8/10

Alexandria’s (ARE) Profit Rebound Comes With A Cash Flow Catch

Alexandria Real Estate Equities (ARE) reported a narrower Q2 2026 net loss of $0.43 per share, but FFO per share declined. Leasing activity improved, with 1.04 million sq. ft. signed, and occupancy reached 90.9%. The company has $3.6B in liquidity and extended its credit line. However, same-property NOI fell 10.6%, and rental rates declined. Net debt to EBITDA is 7.0x, above target.

yahoo.com2 min